Altrinsic Global Advisors LLC Pro Qr Therapeutics N.V. Transaction History

Altrinsic Global Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.9 - $8.39 $289,224 - $2.7 Million	-321,360 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.14 - $9.22 $331,200 - $737,600	80,000 Added 33.15%	321,360 $2.12 Million
Q4 2020 Feb 16, 2021	BUY	$3.58 - $4.85 $71,600 - $97,000	20,000 Added 9.04%	241,360 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $116,800 - $210,200	20,000 Added 9.93%	221,360 $2.19 Million
Q2 2019 Aug 14, 2019	BUY	$9.1 - $15.55 $20,930 - $35,765	2,300 Added 1.16%	201,360 $1.83 Million
Q1 2019 May 14, 2019	BUY	$12.5 - $18.48 $221,250 - $327,096	17,700 Added 9.76%	199,060 $2.76 Million
Q4 2018 Feb 14, 2019	SELL	$15.25 - $22.4 $152,500 - $224,000	-10,000 Reduced 5.23%	181,360 $2.86 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $6.45 $832,415 - $1.23 Million	191,360	191,360 $928,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.